HAIN - The Hain Celestial Group, Inc.
| Previous Close | 23.43 |
| Open | 23.51 |
| Bid | 23.75 x 900 |
| Ask | 23.77 x 800 |
| Day's Range | 23.40 - 23.83 |
| 52 Week Range | 14.45 - 31.53 |
| Volume | 202,325 |
| Avg. Volume | 1,755,306 |
| Market Cap | 2.481B |
| Beta (3Y Monthly) | 1.42 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.30 |
| Earnings Date | May 6, 2019 - May 10, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 21.90 |
- Markit•39 minutes ago
See what the IHS Markit Score report has to say about Hain Celestial Group Inc.
Hain Celestial Group Inc NASDAQ/NGS:HAINView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is moderate Bearish sentimentShort interest | NeutralShort interest is moderately high for HAIN with between 10 and 15% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $2.81 billion over the last one-month into ETFs that hold HAIN are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Goods sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Benzinga•2 days ago
Notable Insider Buys This Past Week: Coty, Symantec and More
Hain Celestial Group Inc (NASDAQ: HAIN) had a director make a few more notable indirect share purchases this past week. This maker of organic and natural products recently posted better than expected quarterly results and announced the sale of its interest in Hain Pure Protein for $80 million.
- Insider Monkey•4 days ago
Engaged Capital’s Latest Moves
Engaged Capital is a hedge fund that was founded in 2012 by Glenn W. Wellin, who previously sharpened his investment skills at famous Relational Investors where he was a Principal and Managing Director. The fund was launched with an initial capital of $85 million, and it has grown big since – holding $796.16 million in […]
- PR Newswire•4 days ago
Hain Celestial Reports Granting of Inducement Award
LAKE SUCCESS, N.Y. , May 17, 2019 /PRNewswire/ -- The Hain Celestial Group, Inc. (Nasdaq: HAIN) ("Hain Celestial" or the "Company"), a leading organic and natural products company with ...
- InvestorPlace•5 days ago
New Regime Will Impact Aphria Stock
No one who follows Aphria (NYSE:APHA stock should have been surprised that the company's president, Jakob Ripshtein, resigned on May 14. Ever since interim CEO Irwin Simon was appointed Independent Chair of Aphria's board in December, it was only a matter of time before Simon, the entrepreneurial founder and former CEO of Hain Celestial (NASDAQ:HAIN), would play a more prominent role at the Canadian cannabis company. Out With the OldSimon stepped down in June 2018 from his role as CEO of Hain after years of sub-standard shareholder returns and a hard-court press from activist investor Engaged Capital.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Stocks to Buy that Lost 10% Last Week Simon owned 1.7% of Hain's stock, but Engaged has an 11.3% stake, so Engaged's founder, Glenn Welling, was appointed to Hain's board in September 2017. Simon remained the chairman of Hain, the same role he now holds at Aphria. At 60 and in reasonably good health, Simon probably isn't ready to devote his life to the golf course and retirement. The resignation of Ripshtein, after Vic Neufeld stepped down as APHA's CEO in January, is another part of the changing of the guard at Aphria. I expect the board to soon remove the interim tag from Simon's current title. The Irwin Simon era at APHA has begun. The New COORipshtein joined Aphria in May 2018 as its chief commercial officer and was promoted to president six months later, before Simon arrived on the scene. While Simon's words of thank to Ripshteins in the company's press release were complimentary, it's clear by Aphria's choice for COO that Simon wasn't comfortable working with Ripshtein, a former CFO of Diageo's (NYSE:DEO) North American operations and former president of the liquor company's Canadian operations. "On behalf of the Board of Directors and Aphria team, we thank Jakob for his contributions to the Company over the past year and wish him well in his future endeavors. He has been instrumental in assembling the incredible team we are fortunate to have today that will carry his responsibilities forward," Irwin stated in Aphria's May 14 press release.The new COO is Jim Meiers, who happens to have come to Aphria after 14 years at Hain Celestial, where he worked alongside Simon. At Hain, Meiers hed several senior executive positions, including president of Celestial Seasonings. Before Hain, he worked at both H.J. Heinz and Kraft Foods. Meiers' hiring suggests two things.First, it's likely Simon wanted someone he could trust to execute Aphria's game plan and someone who's familiar with his style of management. Every change at the top involves a little turnover. I'm sure it wasn't personal. Secondly, Meiers' background suggests that Simon is looking to implement a supply chain which is more appropriate for a food company rather than a medical company. Both, however, require significant oversight, making the appointment a sensible one and positive for Aphria stock. The Bottom Line on Aphria StockThe moves announced May 14 are simply part of the ongoing transformation of Aphria from Vic Neufeld's baby to Irwin Simon's. One of two things is going to happen in the coming months. Either Simon will be appointed the permanent CEO (likely) or Meiers will become the chief executive (less likely but still possible). Given the spotty performance of Hain stock over the past 15 years, I don't know if Simon's rise to power at APHA is, overall, a good thing or a bad thing for the owners of Aphria stock. At the time of this writing Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 10 Retirement Stocks That Won't Wilt in a Bear Market * 5 Consumer Stocks Ready to Push Higher * 3 of the Best ETFs to Buy for a Play on Gold Stocks Compare Brokers The post New Regime Will Impact Aphria Stock appeared first on InvestorPlace.
- PR Newswire•7 days ago
Hain Celestial Announces Appointment of Veteran Consumer Packaged Goods Executive as President, North America
LAKE SUCCESS, N.Y. , May 14, 2019 /PRNewswire/ -- The Hain Celestial Group, Inc. (Nasdaq: HAIN) ("Hain Celestial" or the "Company"), a leading organic and natural products company with ...
- InvestorPlace•7 days ago
There’s a Pretty Strong Speculative Case for Buying Aphria Stock
Amid a disappointing earnings report, Aphria (NYSE:APHA) continues on the path to recovery. Allegations regarding an asset purchase and conflicts of interest in the C suite sent Aphria stock from over $16 per share to under $4 per share for a brief time.Source: Shutterstock However, a new CEO has restored some confidence in the company. The most recent earnings numbers stopped the upward move in APHA for now.Still, with a compelling valuation and a well-regarded consumer industry executive leading the company, APHA could find itself on the way to recovery.InvestorPlace - Stock Market News, Stock Advice & Trading TipsFor the sake of full disclosure, I bought Aphria stock when it still traded on the pink sheets. However, I got out soon after it moved to the New York Stock Exchange. I made this decision when questions about conflicts of interest within the C suite and the legitimacy of its Latin American assets came to light. * 7 Dividend Stocks to Buy as the Trade War Reignites A Closer Look at AphriaFast forward to today, and both CEO Vic Neufeld and co-founder and Cole Cacciavillani have left the company. Further, a review of the purchase determined that Aphria paid a high but acceptable price for legitimate assets in Latin America.Aphria has now appointed Irwin Simon as its interim CEO. Simon founded Hain Celestial (NASDAQ:HAIN) in 1993. Over 25 years, he made it one of the leading natural and organic food companies in the U.S. This has helped restore some confidence in APHA. It also mirrors the situation at GE (NYSE:GE) who has also hired a CEO from the outside with a reputation for success.The existence of recent reputational issues tends to breed mistrust. However, it also leaves more risk-tolerant traders with reasons to buy. Aphria stock trades at a forward price-to-earnings (PE) ratio of 22.9.This comes in well below average multiples in the cannabis industry. Today, marijuana stocks often support price-to-sales (PS) ratios in the triple digits. That also appears cheap when considering predicted earnings increases. Wall Street expects profit growth of 140% this year and 75% in fiscal 2020.I think these factors take Aphria back to where it was before the controversies took place. APHA may never catch up to the likes of Canopy Growth (NYSE:CGC) or Aurora Cannabis (NYSE:ACB) in terms of valuation. Still, CGC supports a PS ratio of just over 140. That same multiple stands at around 20 for APHA stock. This leaves APHA will potential to expand that multiple. APHA Is a Buyout CandidateAnother possibility lies in a buyout. his does not mean the hostile bid like the one recently attempted by Green Growth Brands (OTCMKTS:GGBXF), but one from a larger player.I usually avoid recommending stocks for this reason (buyouts can come at any price level). However, given Aphria's low multiple, buyers will likely look to APHA rather than other cannabis firms.Moreover, it has established a presence in key markets offshore. Yes, it recently divested its U.S. assets. However, it holds the holdings in Latin America which caused issues for the company last year. This includes cultivation acreage in Colombia and Jamaica as well as research-related assets in Argentina.Also, its purchase of Nuuvera brings Aphria into Europe, the Middle East, and Africa. Further, it has recently become one of the few firms to acquire five licenses (the legal maximum) to cultivate weed in Germany. This should bring significant growth for APHA even if they never enter the U.S. Bottom Line on Aphria StockNow that the company has put conflicts of interests behind it, a speculative case for Aphria has emerged. Thanks in part to the lower stock price, the company finds itself in a position where it earns an annual profit and trades well below most of its peers in the cannabis industry.Moreover, a CEO with a track record of success runs the company. Also, though it no longer holds U.S. assets, holdings in other parts of the world should lead Aphria to further growth. Regardless of whether owners of APHA benefit from profit growth or a buyout, the future again appears bright for Aphria stock.As of this writing, Will Healy did not hold a position in any of the aforementioned stocks. You can follow Will on Twitter at @HealyWriting. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Dividend Stocks to Buy as the Trade War Reignites * 10 Stocks That Could Squeeze Short Sellers, Including CGC * 5 Tech Stocks Getting Crushed Compare Brokers The post There's a Pretty Strong Speculative Case for Buying Aphria Stock appeared first on InvestorPlace.
- Thomson Reuters StreetEvents•8 days ago
Edited Transcript of HAIN earnings conference call or presentation 9-May-19 12:30pm GMT
Q3 2019 Hain Celestial Group Inc Earnings Call
- Zacks•11 days ago
Hain Celestial (HAIN) Falls Despite Q3 Earnings & Sales Beat
Hain Celestial's (HAIN) top and bottom lines decline year over year in third-quarter fiscal 2019. Net sales decline across all regions.
Motley Fool•12 days agoHain Celestial Group Inc (HAIN) Q3 2019 Earnings Call Transcript
HAIN earnings call for the period ending March 31, 2019.
- Zacks•12 days ago
Hain Celestial (HAIN) Beats Q3 Earnings and Revenue Estimates
Hain Celestial (HAIN) delivered earnings and revenue surprises of 5.00% and 1.01%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
- Kiplinger•12 days ago
18 Consumer Staples Stocks to Take the Edge Off Your Portfolio
Consumer staples stocks have largely fallen off the radar in recent months. Investors have been much more focused on growth as corporate earnings have pleasantly surprised, the U.S.-China trade spat showed signs of hope and the Federal Reserve decided to keep interest rates steady.Naturally, these more defensive companies haven't been especially red-hot of late. Consumer staples stocks have lagged the marketwide bounce that took shape beginning in late December. But with many other sectors starting to feel the weight of unwieldy gains, and with China trade talks yet again hitting turbulence, the sector might be ready to heat up again.Steve Azoury, founder of financial planning firm Azoury Financial, says, "Consumer staples, the products that people use every day, will always be a big part of America's economy." "The trick," he adds, is identifying the companies that "will stay innovative and update their products and services to excite their customers, and thus the stock prices for investors."Here are 18 of the best consumer staples stocks to invest in at the moment. While some of these are blue-chip stocks that should ring a bell, others are lesser-known companies that serve as the backbone of brands you may be more familiar with. Almost all of them provide varying levels of dividend income. SEE ALSO: 57 Dividend Stocks You Can Count On
- Associated Press•12 days ago
Hain Celestial: Fiscal 3Q Earnings Snapshot
The Lake Success, New York-based company said it had a loss of 63 cents per share. Earnings, adjusted to account for discontinued operations and non-recurring costs, were 21 cents per share. The results ...
- PR Newswire•12 days ago
Hain Celestial Reports Third Quarter Fiscal Year 2019 Financial Results
Transformational Strategic Plan Gaining Traction as Company Reiterates Fiscal Year Guidance Second Consecutive Quarter of Sequential Margin Improvement LAKE SUCCESS, N.Y. , May 9, 2019 /PRNewswire/ -- The ...
- PR Newswire•12 days ago
Hain Celestial Enters Into Definitive Agreement to Sell Hain Pure Protein
LAKE SUCCESS, N.Y., May 9, 2019 /PRNewswire/ -- The Hain Celestial Group, Inc. (HAIN) ("Hain Celestial" or the "Company"), a leading organic and natural products company with operations in North America, Europe, Asia and the Middle East providing consumers with A Healthier Way of Life™, today announced that it has entered into a definitive agreement to sell all of its equity interest in Hain Pure Protein Corporation, which includes the FreeBird™ and Empire® Kosher businesses, to Aterian Investment Partners III, LP for a purchase price of $80 million, subject to adjustments. The transaction is expected to close before June 30, 2019, the end of the Company's fiscal year. "We are pleased to have entered into an agreement for the sale of our remaining Hain Pure Protein businesses," commented Mark L. Schiller, Hain Celestial's President and Chief Executive Officer. "This divestiture is another step forward in simplifying our organization aligned with our transformational strategic plan as we aggressively pursue margin enhancing initiatives to fuel long-term sustainable growth and profitability.
- InvestorPlace•12 days ago
Aphria Stock Just Has Too Much Drama and Not Enough Value
When it comes to marijuana stocks, there always seems to be drama. Hey, it's an industry that is in the hyper growth phase, kind of like what happened during the late 1990s with the dot-coms. But Aphria (NYSE:APHA) has taken the drama to another level. To get a sense of this, just look at the chart. It's been a roller coaster. A year ago, APHA stock went from $8.80 to $14 by September. Then the shares got crushed, plunging to below $6 in early December.Source: Shutterstock Yet this did not mark the end of the volatility of Aphria stock. There was another rally to $10 and yes, the shares would then fall back to $6.Yes, this has been a dream for quick-moving traders. But as for those with a long-term bent, it's been a loser.InvestorPlace - Stock Market News, Stock Advice & Trading TipsSo then why all the volatility? What's going on here? * 10 Great Stocks to Buy on Dips A Closer Look at Aphria StockFirst of all, in December Green Growth Brands (OTCMKTS:GGBXF) launched a buyout bid for the company even though it was much smaller (although, the company had the backing of a billionaire). Yet Green Growth Brands has recently abandoned its buyout effort, and the result was an $89 million payout to Aphria. It appears that a main reason was another example of drama for Aphria stock: its fiscal third quarter earnings report. Simply put, it was downright awful.The company reported a net loss of 20 cents a share and revenues of 74 million CAD. On the other hand, the Street was looking for a more modest loss of 4 cents a share and revenues of 83 million CAD. On the news, Aphria stock dropped about 15%.But this was not the end of the bad news! In response to negative reports from various short sellers, Aphria set up an independent special committee for an investigation of the allegations.The conclusion? Well, it was mixed. On the positive side, the board noted that the assets purchased in Latin America were not a sham (although, the valuations were certainly at high levels). On the negative side, there were examples of conflicts of interest with senior executives, and the CEO and co-founder have since departed.Irwin Simon has come in to take the post as interim CEO. Keep in mind that he has a strong resume, with more than 20 years as the head of Hain Celestial (NASDAQ:HAIN). He looks like the right person to bring some stability to Aphria. Bottom Line on Aphria StockThe growth prospects for cannabis remain strong. According to a research report from the United Nations, the spending is about $150 billion per year. But of course, the near-term opportunity is in Canada, which is expected to see 4.3 billion CAD this year. And in the coming years, we'll likely see more countries legalize cannabis for recreational purposes.There is also the emerging opportunity for cannabidiol (CBD), which is a compound that has shown medical efficacy (such as for pain). In last year's Farm Bill, Congress removed this from the illegal substance list. This is likely to unleash growth in CBD spending in the US.Yet despite all this, I think investors need to be selective with marijuana stocks. And for the most part, there seem to be better alternatives than Aphria stock. Again, the company has to deal with a wrenching transition with its leadership, which will take time, and the financials have been underwhelming.I'd instead look at companies like Cronos (NASDAQ:CRON) and Canopy Growth (NYSE:CGC). They not only have strong production and distribution channels but also the benefit of big-time strategic backers like Altria (NYSE:MO) and Constellation (NYSE:STZ) respectively. Such advantages will definitely make it difficult for other players like Aphria to get an edge.Tom Taulli is the author of High-Profit IPO Strategies, All About Commodities and All About Short Selling. Follow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Great Stocks to Buy on Dips * 6 Growth Stocks to Buy for the Rest of 2019 * 4 Mega-Cap Stocks to Sell Before They Melt Down Compare Brokers The post Aphria Stock Just Has Too Much Drama and Not Enough Value appeared first on InvestorPlace.
- Motley Fool•13 days ago
Kraft Heinz's Accounting Issues Raise Red Flags
Some little accounting mistakes over the past two years are coming back to haunt the packaged foods maker.
- Simply Wall St.•14 days ago
What Investors Should Know About The Hain Celestial Group, Inc.'s (NASDAQ:HAIN) Financial Strength
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Investors are always looking for growth in small-cap stocks like The Hain Celestial Group, Inc. (NASD...
- PR Newswire•15 days ago
Hain Celestial Completes the Sale of WestSoy®
LAKE SUCCESS, N.Y., May 6, 2019 /PRNewswire/ -- The Hain Celestial Group, Inc. (HAIN) ("Hain Celestial" or the "Company"), a leading organic and natural products company with operations in North America, Europe, Asia and the Middle East providing consumers with A Healthier Way of Life™, today announced that it has completed the divestiture of the WestSoy® tofu, seitan and tempeh businesses to Keystone Natural Holdings, a portfolio company of Keystone Capital focusing on plant based food. The strategic divestiture did not include the WestSoy® plant-based beverage business, which has been retained by Hain Celestial. The terms of the transaction were not disclosed.
- Zacks•18 days ago
Hain Celestial (HAIN) to Post Q3 Earnings: What's in Store?
Hain Celestial (HAIN) is concerned about sluggish sales performance across the United States, United Kingdom and Rest of World along with soft margins.
- Insider Monkey•19 days ago
Did Hedge Funds Drop The Ball On The Hain Celestial Group, Inc. (HAIN) ?
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth […]
- Zacks•19 days ago
Analysts Estimate Hain Celestial (HAIN) to Report a Decline in Earnings: What to Look Out for
Hain Celestial (HAIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- InvestorPlace•22 days ago
Bullet-Dodging Aphria Stock Is a Risky, But Rewarding Trade
Almost nothing about the marijuana industry -- legal or otherwise -- is stable or predictable. Aphria (NYSE:APHA) offers further confirmation of this thesis. After going rangebound since mid-February of this year, Aphria stock dropped nearly 15% on tax day. The reason? A very poor earnings result for the fiscal third quarter of 2019.Source: MarihuanayMedicina via FlickrAnalysts expected APHA to lose 4.5 cents CAD per share. Instead, the actual earnings per share came in at a staggering loss of 20 cents CAD. Moreover, the optics were absolutely horrible compared to the year-ago quarter, when Aphria delivered an EPS of 8 cents CAD.This translated to a net loss of 108.2 million CAD. This also compared very unfavorable to Q3 2018's net income of 12.94 million CAD. Therefore, it doesn't take a rocket scientist to see why investors quickly soured on APHA stock.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Dividend Stocks That Could Double Over the Next Five Years Even worse for shareholders, the pain continued beyond the earnings fallout. Two days after the Q3 disclosure, Aphria stock suffered another double-digit loss. As of the time of writing, the cannabis firm is down a little over 30% from its 2019 highs in early February.However, year to date, APHA stock has gained 25%, even with the recent volatility considered. So, can investors expect more downside, or is APHA a worthwhile contrarian opportunity? The Dark Cloud over Aphria StockLate last year, Hindenburg Research made a startling accusation. In a no-holds-barred expose, the company stated that Aphria was nothing more than a "shell game with a cannabis business on the side."A second report later added to the credibility stain that Aphria stock incurred. Sure, marijuana firms have been on the wrong side of short-sellers before. For instance, Citron Research called out Cronos Group (NASDAQ:CRON) for deceptive business practices. But this time, the allegations were very specific and unsettling.Most analysts got two key takeaways from the crackdown on APHA stock. First, Aphria's management team spent more than $200 million on "largely worthless" assets. Second, the executives had a financial stake in the acquired assets.Thus, we had a classic conflict of interest. Management worked hard to ink a deal that only benefitted them, not the shareholders of Aphria stock. At the very least, it was a violation of fiduciary duty. An Exoneration for APHA Stock…Sort ofAfter months of deafening silence, Aphria's leadership team finally responded. Actually, an independent special committee that the company's board of directors revealed their findings. Their report was both an exoneration and condemnation of APHA stock, depending on your perspective.First, the bad news: the committee noted that not everyone involved in the asset acquisitions were on the up and up. That sparked serious changes at the top. As our own Ian Bezek noted, former Aphria CEO Vic Neufeld stepped down, as did co-founder Cole Cacciavillani. For now, the company appointed Irwin Simon as interim CEO. Simon previously led Hain Celestial (NASDAQ:HAIN) for more than two decades.Again, no advanced degree in rocket science is necessary to understand the negative implications. Legal marijuana is a budding (no pun intended) industry. The sector must still overcome federal restrictions. Shady dealings like this do no favors for anyone involved.However, we do have some good news: those "worthless" assets? Turns out, they're not so worthless after all. The investigation revealed that the prices paid were "near the top end of a reasonable price range," as Bezek wrote. While costly, the assets provided genuine business benefits for Aphria stock. APHA Dodges a Bullet, but You Could Ride OneLooking back at the investigation's results, I believe the facts are net favorable to Aphria.First, Bezek and many other analysts are correct: the cannabis industry is the Wild West of the markets. You're going to see astounding wins in this sector. Along the way, though, most players will suffer devastating losses.With the conflicted interests of Aphria's leadership team, the controversy only confirmed this negative image. Yet, let's look at this from a forward-thinking perspective. Everyone in the cannabis trade knows -- if they didn't already -- that they're being watched. To try any more shenanigans at this point is almost suicidal.Second, Aphria stock dodged a bullet. The assets under question turned out to be genuine producers. It suggests that the company's other dealings were also perfectly legitimate. Subsequently, revenue growth was one of the few bright spots for Q3 2019.APHA rang up 73.6 million CAD, up substantially from the 10.3 million CAD of the year-ago level. In addition, the company's financial statements reveal that they're steadily moving inventory, a common concern among marijuana producers. * 7 A-Rated Stocks That Are Under $10 All in all, Aphria stock looks interesting as a speculative trade here. The bad news appears baked in, and some of it is actually good news. Of course, I'd be incredibly careful like any other cannabis play. Ultimately, though, the pros outweigh the cons.As of this writing, Josh Enomoto did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Dividend Stocks That Could Double Over the Next Five Years * 6 S&P 500 Stocks Ready to Break Out * 5 Mining ETFs to Dig Into Compare Brokers The post Bullet-Dodging Aphria Stock Is a Risky, But Rewarding Trade appeared first on InvestorPlace.
